Eren Bali Profile picture
27 Dec, 11 tweets, 2 min read
We have spent a ridiculous amount of time trying to bring full price transparency to healthcare payments but haven’t been able to make much progress. Let me explain why this is hard 🧵
Our goal is to predict patient responsibility of a visit as soon as possible. Ideally this would be calculated real-time in our EHR so that clinicians can do cost/value trade offs with the patient while ordering things that impact the cost (procedures, diagnostic tests, etc)
The main independent variables here are
1) Complexity of the evaluation (usually 1-5)
2) Additional services like labs, procedures, medical imaging etc which are modeled as CPT codes
3) The nature of the work done (preventive, sick visit, etc) which are mapped to service types
4) Coverage of the insurance plan by service type. This is far more complex than United vs Cigna. Each plan may have arbitrary rules that impacts coverage + HMO/ACO/EPOs complicate things further
5) Contracted rates between provider and network (not the insurance or the plan).
6) Remaining deductible
7) Other details like the clinician type, modality, location etc.

The first challenge is to generate claim details (mostly CPT codes) real-time in your EHR. This is a solvable design problem. You can solve price transparency for self pay patients with it.
Next you have to get very granular details of the insurance plan. Clearing house APIs give you some of this but you hit an “edge case” 20-30% of the time.

Next challenge is digitizing your contracts which is 100x harder than it should be but Rivet Health does help here.
Here is the biggest challenge: with the exact same plan, CPT code, same literally everything you get 100s of different “total allowed amount”s from the insurance companies. On theory the allowed amount should match the contracted rates, but it only does ~40% of the time.
Two underlying problems here. First, there are a ton of things that influence “the contract” which are opaque to the provider. Secondly, insurance companies still employ an army of humans to respond to claims. You get everything from inconsistent interpretation to missing digits.
Price transparency with the incomplete data we have is really hard, particularly because an inaccurate prediction may be worse than no prediction. Companies like Oscar have automated claim processing systems, but legacy insurance infrastructures can’t support this.
I’m guessing the solution will be getting rid of the complexity altogether (case rates, full capitation, etc). Unfortunately a lot of efforts to “reduce cost” are making things even more complicated and thus indirectly increase the cost.
I should sit down and write a detailed article about this and have our team fact check it. Take this as a directionally accurate portrayal of the challenge.

• • •

Missing some Tweet in this thread? You can try to force a refresh
 

Keep Current with Eren Bali

Eren Bali Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

PDF

Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

More from @erenbali

24 Jun
1/ I came to this country 10 years ago on an H1B visa. In this period I started 2 companies: @udemy and @CarbonHealth. Udemy now employs ~700 people, provides ongoing income to 50k instructors and improves employability of tens of millions of Americans by helping close skill gaps
2/ @CarbonHealth employs ~350 ppl and will create 10s of thousands of jobs + health care access in many underserved communities. In addition to working on the frontlines of the pandemic, we have been helping companies reopen safely and thus retain employees.
3/ And this is not just about the immigrant founders. There are million of employees on work visas that are vital to the success of many tech companies. The recent ban on H1, L and J visas will do nothing but hurt companies and cause increased unemployment
whitehouse.gov/presidential-a…
Read 13 tweets
23 Mar
1/ Important update: This evening, our lab partner notified us that the FDA updated their FAQ about COVID-19 testing. The update clarifies that at-home sample collection is not covered under the EUA (emergency use authorization)
fda.gov/medical-device…
2/ We (@CarbonHealth) are discontinuing the distribution of at-home sample collection kits and contacting the first group of patients to schedule expedited testing in our clinics. FDA supports at-home collection but needs more data to validate its accuracy.
3/ We're doing 50-100 COVID-19 tests in our clinics every day. We will continue to look for additional ways to expand testing capacity. We still believe in the value of at-home sample collection so we will work with our lab partners to accelerate data collection.
Read 4 tweets

Did Thread Reader help you today?

Support us! We are indie developers!


This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Too expensive? Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal Become our Patreon

Thank you for your support!

Follow Us on Twitter!